Non-sedating Antihistamine (H1 Antagonist — Second-generation)
Pregnancy: Considered acceptable in pregnancy — most safety data among second-generation antihistamines. RCOG recommends loratadine or cetirizine in pregnancy.
Loratadine
Brand names: Clarityn, Benadryl Once A Day
Adult dose
Dose: Allergic rhinitis, urticaria: 10mg OD
Route: Oral
Frequency: Once daily
Max: 10mg OD
Second-generation antihistamine — minimal sedation, no anticholinergic effects, does not cross blood-brain barrier significantly. Once-daily dosing. Available OTC. No QTc prolongation (unlike terfenadine, its predecessor). Preferred antihistamine when patients need to drive or operate machinery.
Paediatric dose
Route: Oral
Frequency: Once daily
Max: 10mg OD
BNFc: 2–11 years (body weight <30kg): 5mg OD; (≥30kg): 10mg OD. 12–17 years: 10mg OD. Syrup available (5mg/5mL).
Dose adjustments
Renal
eGFR <30: increase dosing interval to alternate days (every 48h).
Hepatic
Hepatic impairment: increase dosing interval to every 48h — hepatically metabolised to active desloratadine.
Clinical pearls
- Non-sedating at standard doses — suitable for patients who drive; cetirizine causes more sedation in some patients (individual variation)
- Preferred over chlorphenamine for regular/daily use in allergic rhinitis — non-sedating and once-daily; chlorphenamine is better for acute severe urticaria or anaphylaxis (faster onset and more potent)
- Metabolised to desloratadine (active) — desloratadine is available separately (Neoclarityn) with similar profile and may be slightly more potent
- Available OTC without prescription — good first-line recommendation for hay fever season
Contraindications
- Hypersensitivity to loratadine
Side effects
- Headache (most common)
- Drowsiness (minimal at standard dose)
- Dry mouth (minimal anticholinergic effect)
- Fatigue
Interactions
- CYP3A4/CYP2D6 inhibitors (ketoconazole, erythromycin) — increase loratadine levels; avoid combination or monitor for sedation
- Alcohol — may cause minor additive sedation
Monitoring
- Symptom control (allergic rhinitis / urticaria)
- No routine monitoring required
Reference: BNFc; BNF 90; NICE CG134 (Allergic Rhinitis). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023